Vanderbilt University Medical Center is studying the effects of three “repurposed” drugs in treating mild and moderate symptoms of COVID-19.
The study, in partnership with the Duke University Clinical Research Institute, will examine the effectiveness of Ivermectin, Fluvoxamine, or Fluticasone on the symptoms of the illness.
Read More